Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-08 12:00 pm Sale | 13G | PROGENICS PHARMACEUTICALS INC PGNX | FARALLON CAPITAL MANAGEMENT LLC | 0 0% | -8,500,000 (Position Closed) | View |
| 2021-02-12 6:42 pm Purchase | 13G | PROGENICS PHARMACEUTICALS INC PGNX | FARALLON CAPITAL MANAGEMENT LLC | 8,500,000 9.8% | 250,000 (+3.03%) | View |
| 2020-06-23 10:26 am Sale | 13D | PROGENICS PHARMACEUTICALS INC PGNX | Lantheus Holdings Inc. LNTH | 1,000 100% | -8,010,733 (-99.99%) | View |
| 2020-06-04 4:06 pm Sale | 13G | PROGENICS PHARMACEUTICALS INC PGNX | EAGLE ASSET MANAGEMENT INC | 31 5% | -4,506,253 (-100.00%) | View |
| 2020-04-23 5:00 pm Purchase | 13D | PROGENICS PHARMACEUTICALS INC PGNX | Lantheus Holdings Inc. LNTH | 8,011,733 9.3% | 8,011,733 (New Position) | View |
| 2020-04-15 3:15 pm Unchanged | 13D | PROGENICS PHARMACEUTICALS INC PGNX | Altiva Management Inc. | 8,011,733 9.3% | 0 (Unchanged) | View |
| 2020-04-09 4:49 pm Unchanged | 13D | PROGENICS PHARMACEUTICALS INC PGNX | Altiva Management Inc. | 8,011,733 9.3% | 0 (Unchanged) | View |
| 2020-02-14 1:29 pm Purchase | 13G | PROGENICS PHARMACEUTICALS INC PGNX | PRICE T ROWE ASSOCIATES INC | 4,990,790 5.7% | 4,990,790 (New Position) | View |
| 2020-02-14 11:25 am Sale | 13G | PROGENICS PHARMACEUTICALS INC PGNX | ARMISTICE CAPITAL LLC | 0 0% | -5,700,000 (Position Closed) | View |
| 2020-02-14 06:19 am Purchase | 13G | PROGENICS PHARMACEUTICALS INC PGNX | FARALLON CAPITAL MANAGEMENT LLC | 8,250,000 9.5% | 3,574,433 (+76.45%) | View |
| 2020-02-13 12:11 pm Sale | 13G | PROGENICS PHARMACEUTICALS INC PGNX | STATE STREET CORP STT | 4,395,011 5.09% | -756,517 (-14.69%) | View |
| 2020-02-11 4:40 pm Purchase | 13G | PROGENICS PHARMACEUTICALS INC PGNX | VANGUARD GROUP INC | 5,703,951 6.6% | 2,146,364 (+60.33%) | View |
| 2020-02-04 12:30 pm Purchase | 13G | PROGENICS PHARMACEUTICALS INC PGNX | BlackRock Inc. BLK | 14,288,924 16.5% | 758,161 (+5.60%) | View |
| 2020-01-06 12:23 pm Purchase | 13G | PROGENICS PHARMACEUTICALS INC PGNX | EAGLE ASSET MANAGEMENT INC | 4,506,284 5.21% | 10,919 (+0.24%) | View |
| 2019-11-12 1:47 pm Unchanged | 13D | PROGENICS PHARMACEUTICALS INC PGNX | Altiva Management Inc. | 8,011,733 9.3% | 0 (Unchanged) | View |
| 2019-09-19 5:23 pm Purchase | 13D | PROGENICS PHARMACEUTICALS INC PGNX | Altiva Management Inc. | 8,011,733 9.3% | 593,061 (+7.99%) | View |
| 2019-08-26 5:02 pm Purchase | 13D | PROGENICS PHARMACEUTICALS INC PGNX | Altiva Management Inc. | 7,418,672 8.6% | 1,388,672 (+23.03%) | View |
| 2019-06-24 4:39 pm Purchase | 13G | PROGENICS PHARMACEUTICALS INC PGNX | FARALLON CAPITAL MANAGEMENT LLC | 4,675,567 5.4% | 4,675,567 (New Position) | View |